http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2020046663-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c93397b5e656a7f10d26f050603b8d89
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2800-91
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-454
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-195
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-197
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-735
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L15-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-44
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L15-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-195
filingDate 2019-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3a5ad680d0ec646da7aa068b731742d5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f72fd707c96a49b8122eb919ad826c8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8c7ec9baddb6fa091db24648b715b4d7
publicationDate 2020-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2020046663-A1
titleOfInvention Methods to enhance a non-surgical medical treatment
abstract In an embodiment, a method to enhance a non-surgical medical treatment, the method including applying a composition having an antifibrinolytic agent to an area of skin for non-surgical medical treatment, where the applying is at least one of before, during, and after the non-surgical medical treatment, beginning the non-surgical medical treatment to the area of skin, and continuing the non-surgical medical treatment until the non-surgical medical treatment is completed. In some embodiments, the antifibrinolytic agent is tranexamic acid in an amount of about 20% (w/v). In some embodiments, the method further includes minimizing, by the antifibrinolytic agent, bruising caused by the non-surgical medical treatment. In an additional embodiment, the present disclosure relates to a composition to enhance a non-surgical medical treatment, the composition having an antifibrinolytic agent. In a further embodiment, the present disclosure relates to a kit having a carrier and an antifibrinolytic agent.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11458044-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11622893-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11583430-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11452808-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11642324-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11286601-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11723808-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11628093-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11116884-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11740241-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11266774-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11241339-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11654057-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11241525-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023283339-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11135315-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11771819-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11331221-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11596554-B2
priorityDate 2017-04-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396296
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226414555
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226407101
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID564
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7107
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8980
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405724
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID688096
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5816
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226407194
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5526
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395920
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID838
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395919

Total number of triples: 63.